C. Pivot

Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents

Julien Jean, Yves Perrodin, C. Pivot et al. · Journal of Environmental Management · 2012 · 98 citations

Drug Analysis, Bioaccumulable Pharmaceutical Substances, Hospital Effluents +9

Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial

Laure Peter‐Derex, Frédéric Philippeau, Pierre Garnier et al. · The Lancet Neurology · 2022 · 61 citations

Prophylactic Levetiracetam, Medicine, Psychotropic Medication +10

Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study

Franck E. Nicolini, Gabriel Étienne, Viviane Dubruille et al. · The Lancet Haematology · 2015 · 53 citations

Hematological Malignancy, Open-label Phase 2, Medicine +8

Ex vivo study of bevacizumab transport through porcine nasal mucosa

Géraldine Samson, Alicia García de la Calera, Sophie Dupuis‐Girod et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2011 · 53 citations

Allergy, Medicine, Immunology +2

Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation

D. Salmon, Elisa Pont, H. Chevallard et al. · International Journal of Pharmaceutics · 2013 · 40 citations

Drug Safety, Safety Considerations, Patient Safety +8